By Sreetama Dutt M.Sc. Severe acute respiratory coronavirus 2 (SARS-CoV-2) has affected millions with coronavirus disease 2019 (COVID-19). Despite vaccines being available to prevent severe disease and hospitalization, there is a lack of a definite antiviral therapy to cure the infection. Study: Enisamium Inhibits SARS-CoV-2 RNA Synthesis. Image Credit: Andrii Vodolazhskyi/ Shutterstock Available antiviral strategies include...
Biocompatible thin film to make thermotherapy more common. Tokyo Tech researchers have developed a small, flexible thin film device that can be implanted in the body and powered wirelessly to generate heat. Utilizing induction heating, a magnetic field is applied to the device from outside the body, raising the temperature of the contacting internal tissue. And since...
CONN HASTINGS EXCLUSIVE, NEUROLOGY, REHAB Evolution Devices, a company based in California, created a functional electrical stimulation device to assist people with foot drop to walk more freely. Foot drop is caused by muscle weakness/paralysis, and those affected struggle to lift the front part of their foot, which makes walking difficult and can lead to falls. The product...
New process combining infrared light and machine learning shows potential to break barriers in disease detection. Illustration by Jenny Nuss/Berkeley Lab A technology developed by scientists at Lawrence Berkeley National Laboratory (Berkeley Lab) shows great promise for diagnosing Alzheimer’s disease before symptoms arise, potentially changing the course of research and treatment for this condition, which affects millions of...
RICHMOND, Va. (Oct. 5, 2021) — Sense of smell or taste returns within six months for 4 out of every 5 COVID-19 survivors who have lost these senses, and those under 40 are more likely to recover these senses than older adults, an ongoing Virginia Commonwealth University study found. Among 798 respondents to the ongoing COVID-19...
CLEVELAND, Ohio (Oct. 5, 2021)—Although hormone therapy (HT) remains the most effective treatment for menopause symptoms, some women have hesitated to use it because of concerns about various adverse health effects. A new study, however, is reducing some of those concerns, showing no increased risk of heart disease or type 2 diabetes relative to HT...
IMAGE: (A–E) FIVE REPRESENTATIVE DEGS BETWEEN TWO GROUPS. *P < 0.05, **P < 0.01, ***P < 0.001. CREDIT: CORRESPONDENCE TO: YAN JIANG Aging-US published “N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions” which reported that the authors systematically investigated the molecular alterations of m6A regulators and their clinical relevance with cognitive dysfunctions using published...
PHILADELPHIA – Chinese Americans and Laotian Americans were over 10 and 14 times more likely to be diagnosed with nasopharyngeal cancer, respectively, than non-Hispanic white Americans, with incidence rates surpassing other Asian American subgroups, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically...
by American Association for Cancer Research Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia Black/African American patients with prostate cancer who were treated with the androgen receptor inhibitor darolutamide (Nubeqa) had clinical outcomes similar to those observed in the overall clinical trial population, according to results from the ARAMIS phase III...
by Tyler Stahle, Brigham Young University Ph.D. graduate, Dr. Tsz-Yin Chan, who studied TNK1 alongside BYU professor Dr. Josh Andersen for the past six years, holds a vial of the newly created drug that is now ready for clinical trials. Credit: Jaren Wilkey/BYU Photo Another important step in the fight against cancer has been enabled thanks...
